| Followers | 425 |
| Posts | 20207 |
| Boards Moderated | 1 |
| Alias Born | 02/22/2010 |
Wednesday, August 03, 2016 2:05:36 PM
CFRX 2.45 ahead of #superbugs in Brazil Huge Inside Buying and Stakes Increased
CFRX An institutional investor recently raised its position in ContraFect Corp. stock. Adage Capital Partners GP L.L.C. increased its position in ContraFect Corp. (NASDAQ:CFRX) by 50.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 1,500,000 shares of the company’s stock after buying an additional 500,000 shares during the period. Adage Capital Partners GP L.L.C. owned approximately 5.46% of ContraFect Corp. worth $5,100,000 at the end of the most recent reporting period.
In other news, CEO Steven C. Gilman acquired 20,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were acquired at an average price of $2.48 per share, for a total transaction of $49,600.00. Following the completion of the transaction, the chief executive officer now directly owns 20,000 shares of the company’s stock, valued at approximately $49,600. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.
$CFRX, a microcap biotech got money from hedge fund from Cormorant Asset that raised stake by 3.42mln sh to hold 9.9% 4.25mln sh as of 7/22.
$CFRX tightly owned with small float
http://www.ecowatch.com/the-rio-olympics-superbugs-sewage-scandal-1955764161.html
CFRX An institutional investor recently raised its position in ContraFect Corp. stock. Adage Capital Partners GP L.L.C. increased its position in ContraFect Corp. (NASDAQ:CFRX) by 50.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 1,500,000 shares of the company’s stock after buying an additional 500,000 shares during the period. Adage Capital Partners GP L.L.C. owned approximately 5.46% of ContraFect Corp. worth $5,100,000 at the end of the most recent reporting period.
In other news, CEO Steven C. Gilman acquired 20,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were acquired at an average price of $2.48 per share, for a total transaction of $49,600.00. Following the completion of the transaction, the chief executive officer now directly owns 20,000 shares of the company’s stock, valued at approximately $49,600. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.
$CFRX, a microcap biotech got money from hedge fund from Cormorant Asset that raised stake by 3.42mln sh to hold 9.9% 4.25mln sh as of 7/22.
$CFRX tightly owned with small float
http://www.ecowatch.com/the-rio-olympics-superbugs-sewage-scandal-1955764161.html
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
